pdufa.bio
Home › Screener

Biotech catalyst screener

Every FDA catalyst in one filterable view, PDUFA decisions, clinical-trial readouts, medical conferences, and FDA advisory committee meetings. Filter by ticker, event type, therapeutic area, and date.

PDUFAReadoutsConferencesAdComm
About · Corrections · Changelog · Glossary · Methodology

Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.

Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.

© 2026 pdufa.bio. All rights reserved.
Next 120 catalysts: server-rendered. Sorting and filtering load with JavaScript; this table is the same data without it.
TickerDateTypeDrugArea
REPL2026-08-02PDUFARP1 (vusolimogene oderparepvec) + nivolumabOncology
MRNA2026-08-05PDUFAmRNA-1010 - (P304)
LNTH2026-08-13PDUFAMK-6240
BMRN2026-08-15 (est.)ReadoutVosoritideOther
INCY2026-08-15 (est.)ReadoutRuxolitinibOther
JSPR2026-08-15 (est.)ReadoutBriquilimabOther
MIRM2026-08-15 (est.)ReadoutBrelovitugInfectious
MRK2026-08-15 (est.)ReadoutEnsifentrineOther
NVO2026-08-15 (est.)ReadoutSemaglutideOther
PHVS2026-08-15 (est.)ReadoutdeucrictibantOther
RGNX2026-08-15 (est.)ReadoutRanibizumabOphthalmology
VSTM2026-08-15 (est.)ReadoutavutometinibOther
BMY2026-08-17PDUFAiberdomide, daratumumab, and dexamethasone vs. darat
CAPR2026-08-22PDUFADeramiocel (CAP-1002) - (HOPE-2)
RARE2026-08-23PDUFADTX401 AAV gene therapy (pariglasgene brecaparvovec)
JAZZ2026-08-25PDUFAZiihera (zanidatamab-hrii) - (HERIZON-GEA-01)
ZYME2026-08-25PDUFAZiihera (zanidatamab-hrii) - (HERIZON-GEA-01)
GILD2026-08-27PDUFABictegravir and Lenacapavir - (ARTISTRY-2)
REGN2026-08-31PDUFAGaretosmab - (OPTIMA)
TLX2026-09-11PDUFATLX101-Px
ARQT2026-09-15 (est.)ReadoutTopical RoflumilastOther
ARVN2026-09-15 (est.)ReadoutARV-471Oncology
BHVN2026-09-15 (est.)ReadoutTaldefgrobep AlfaMetabolic
BIIB2026-09-15 (est.)ReadoutLitifilimabImmunology
BMY2026-09-15 (est.)ReadoutBevacizumabOther
CGEM2026-09-15 (est.)ReadoutCLN-081Hematology
CORT2026-09-15 (est.)ReadoutRelacorilantInfectious
EXEL2026-09-15 (est.)ReadoutCabozantinibOther
GILD2026-09-15 (est.)ReadoutSacituzumab GovitecanOncology
IBRX2026-09-15 (est.)ReadoutALT-803Oncology
IRON2026-09-15 (est.)ReadoutDISC-1459Other
MRK2026-09-15 (est.)ReadoutPembrolizumabOncology
SNDX2026-09-15 (est.)ReadoutRevumenibOther
SUPN2026-09-15 (est.)ReadoutSPN-812Other
VERA2026-09-15 (est.)ReadoutAtaciceptNephrology
VNDA2026-09-15 (est.)ReadoutVSJ-110Ophthalmology
WVE2026-09-15 (est.)ReadoutWVE-210201Other
NUVL2026-09-18PDUFAZidesamtinib (NVL-520) - (ARROS-1)
RARE2026-09-19PDUFAUX111 - (ABO-102)
IONS2026-09-22PDUFAZilganersen (ION373)
INCY2026-09-26PDUFAzilurgisertib
MIRM2026-09-26PDUFAzilurgisertib
BFRI2026-09-28PDUFAAmeluz (aminolevulinic acid hydrochloride) topical g
PFE2026-09-30PDUFABrepocitinib (VALOR)
PTGX2026-09-30PDUFARusfertide - (REVIVE)
ROIV2026-09-30PDUFABrepocitinib - (VALOR)
TAK2026-09-30PDUFAOveporexton (TAK-861-2001)
MRK2026-10-10PDUFAIfinatamab deruxtecan (I-DXd)
BIIB2026-10-15 (est.)ReadoutLitifilimabImmunology
CLDX2026-10-15 (est.)ReadoutBarzolvolimabOther
CSLLY2026-10-15 (est.)ReadoutRecombinant Single-Chain Factor ViiiOther
INBX2026-10-15 (est.)ReadoutINBRX-106Other
INCY2026-10-15 (est.)ReadoutPovorcitinibOther
JSPR2026-10-15 (est.)ReadoutBriquilimabOther
MIRM2026-10-15 (est.)ReadoutMaralixibatOther
MRK2026-10-15 (est.)ReadoutPembrolizumabOncology
OGN2026-10-15 (est.)Readout150μg CFA (Elonva®) at stimulation day (SD) 1 anImmunology
PFE2026-10-15 (est.)ReadoutPalbociclibOther
RYTM2026-10-15 (est.)ReadoutSetmelanotideRare disease
SNY2026-10-15 (est.)ReadoutVenglustatOther
SRPT2026-10-15 (est.)ReadoutEteplirsenRare disease
VTRS2026-10-15 (est.)ReadoutCenerimodImmunology
VTRS2026-10-17PDUFAMR-141
PHAR2026-10-24PDUFALeniolisib
GSK2026-10-26PDUFABepirovirsen - (B-Well)
INO2026-10-30PDUFAINO-3107 DNA immunotherapy
AGIO2026-11-01PDUFAMitapivat (PYRUKYND) - (RISE UP)
BTAI2026-11-14PDUFAIGALMI (dexmedetomidine sublingual film) - (SERENITY
CYTK2026-11-14PDUFAAficamten - (MAPLE-HCM)
SMMT2026-11-14PDUFAIvonescimab
CGEM2026-11-15 (est.)ReadoutCLN-081Other
GILD2026-11-15 (est.)ReadoutSacituzumab GovitecanOther
ONC2026-11-15 (est.)ReadoutBGB-11417Hematology
PHAR2026-11-15 (est.)ReadoutLeniolisibOther
SNY2026-11-15 (est.)ReadoutRilzabrutinibOther
TLX2026-11-15 (est.)Readout177Lu-TLX591Other
SVRA2026-11-22PDUFAMOLBREEVI (molgramostim inhalation) - (IMPALA-2)
BBIO2026-11-27PDUFABBP-418 (ribitol) - (FORTIFY)
NUVL2026-11-27PDUFANeladalkib (NVL-655) - (ALKOVE-1)
BAYRY2026-11-30PDUFASevabertinib (BAY 2927088)
COGT2026-11-30PDUFABezuclastinib + sunitinib - (PEAK)
REGN2026-11-30PDUFACemdisiran + pozelimab (C5 combo) - (NIMBLE)
RHHBY2026-11-30PDUFAGiredestrant (lidERA)
VRTX2026-11-30PDUFAPovetacicept (ALPN-303)
EXEL2026-12-03PDUFAZanzalintinib (XL092) + atezolizumab - (STELLAR-303)
VNDA2026-12-12PDUFAImsidolimab
ADCT2026-12-15 (est.)ReadoutLoncastuximab TesirineOncology
ARVN2026-12-15 (est.)ReadoutARV-471Oncology
BIIB2026-12-15 (est.)ReadoutFelzartamabOther
BMY2026-12-15 (est.)ReadoutNivolumabOncology
CMPX2026-12-15 (est.)ReadoutCTX-009Oncology
CNTA2026-12-15 (est.)ReadoutcleminorextonOther
CORT2026-12-15 (est.)ReadoutRelacorilantRare disease
EXEL2026-12-15 (est.)ReadoutCabozantinibOther
INO2026-12-15 (est.)ReadoutVGX-3100Other
INSM2026-12-15 (est.)ReadoutTreprostinil Palmitil Inhalation PowderCardiovascular
IONS2026-12-15 (est.)ReadoutDonidalorsenOther
JAZZ2026-12-15 (est.)ReadoutCPX-351Hematology
MRK2026-12-15 (est.)ReadoutPembrolizumabOncology
NVO2026-12-15 (est.)ReadoutSemaglutideOther
ONC2026-12-15 (est.)ReadoutZanubrutinibOther
PFE2026-12-15 (est.)ReadoutElranatamabHematology
RGNX2026-12-15 (est.)ReadoutRanibizumabOther
SMMT2026-12-15 (est.)ReadoutIvonescimabOncology
SNDX2026-12-15 (est.)ReadoutRevumenibHematology
SNY2026-12-15 (est.)ReadoutRilzabrutinibOther
SUPN2026-12-15 (est.)ReadoutBIS-001Other
TRAW2026-12-15 (est.)ReadoutrigosertibInfectious
VNDA2026-12-15 (est.)ReadoutVQW-765Other
XNCR2026-12-15 (est.)ReadoutXMAB20717Oncology
RHHBY2026-12-18PDUFAGiredestrant (+ everolimus)
MLYS2026-12-22PDUFAlorundrostat Dose 1
PRAX2026-12-27PDUFARelutrigine (PRAX-562) - (EMBOLD)
COGT2026-12-30PDUFABezuclastinib (CGT9486) - (SUMMIT)
ABBV2026-12-31PDUFATavapadon (TEMPO)
AZN2026-12-31PDUFAUltomiris (ravulizumab)
BAYRY2026-12-31PDUFAKERENDIA (finerenone)
NVO2026-12-31PDUFACagriSema (AM833)
NUVB2027-01-04PDUFAIBTROZI (taletrectinib) sNDA
IBRX2027-01-06PDUFAANKTIVA (N-803) + BCG